FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048451330> ?p ?o ?g. }

• W2048451330 endingPage "1559" @default.
• W2048451330 startingPage "1551" @default.
• W2048451330 abstract "Doxorubicin (DOX), a broad‑spectrum anthra­cyclin, is in wide clinical use for the treatment and prevention of thyroid cancer. However, the effectiveness of the treatment remains limited due to inherent tumor resistance to DOX. Results of a previous study demonstrated that downregulation of NIN1/RPN12 binding protein 1 homolog (NOB1) expression via adenovirus expression vector carrying NOB1 siRNA (Ad/sh-NOB1) induced cancer apoptosis and increased the radiosensitivity of papillary thyroid carcinoma (PTC) cells. However, whether knockout NOB1 can decrease DOX resistance remains unclear. Therefore, in the present study, the effect of Ad/sh-NOB1 infection, independently or in combination with DOX, was determined in a PTC cell line to identify more effective therapeutics against PTC cancer. Furthermore, tumor growth ability in nude mice was determined to identify the combination treatment effect in tumorigenesis in vivo. The results showed that Ad/sh-NOB1 combined with DOX treatment in PTC cells significantly suppressed proliferation, colony formation, migration and invasion, and induced cell apoptosis and arrest in the G0/G1 stage as compared to Ad/sh-NOB1 or DOX monotherapy. We also found that this combination suppressed the tumor growth of a nude mouse model as compared to Ad/sh-NOB1 or DOX monotherapy. In addition, Ad/sh-NOB1 combined with DOX treatment significantly increased activation of the p38 MAPK pathway, which may contribute to inhibition of PTC cell growth and decreased DOX resistance. Taken together, the experimental results indicate that Ad/sh-NOB1 combined with DOX treatment is a potential drug candidate for the treatment of papillary thyroid carcinoma." @default.
• W2048451330 created "2016-06-24" @default.
• W2048451330 creator A5002974139 @default.
• W2048451330 creator A5003681868 @default.
• W2048451330 creator A5006452750 @default.
• W2048451330 creator A5057117256 @default.
• W2048451330 creator A5070828891 @default.
• W2048451330 creator A5078536360 @default.
• W2048451330 creator A5079244166 @default.
• W2048451330 creator A5091168983 @default.
• W2048451330 date "2015-01-15" @default.
• W2048451330 modified "2023-10-01" @default.
• W2048451330 title "Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo" @default.
• W2048451330 cites W1970007836 @default.
• W2048451330 cites W1973825222 @default.
• W2048451330 cites W1974077091 @default.
• W2048451330 cites W1987365454 @default.
• W2048451330 cites W2006434892 @default.
• W2048451330 cites W2013039026 @default.
• W2048451330 cites W2015880744 @default.
• W2048451330 cites W2033222884 @default.
• W2048451330 cites W2050781713 @default.
• W2048451330 cites W2062289724 @default.
• W2048451330 cites W2070492313 @default.
• W2048451330 cites W2091378741 @default.
• W2048451330 cites W2094428504 @default.
• W2048451330 cites W2094820755 @default.
• W2048451330 cites W2101199478 @default.
• W2048451330 cites W2102897174 @default.
• W2048451330 cites W2109544257 @default.
• W2048451330 cites W2119683725 @default.
• W2048451330 cites W2128212057 @default.
• W2048451330 cites W2132296761 @default.
• W2048451330 cites W2140279988 @default.
• W2048451330 cites W2152382138 @default.
• W2048451330 cites W2152797436 @default.
• W2048451330 cites W2166946831 @default.
• W2048451330 cites W2171701563 @default.
• W2048451330 cites W2471993313 @default.
• W2048451330 cites W3011541459 @default.
• W2048451330 cites W3150138548 @default.
• W2048451330 cites W4250641604 @default.
• W2048451330 doi "https://doi.org/10.3892/or.2015.3730" @default.
• W2048451330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25592304" @default.
• W2048451330 hasPublicationYear "2015" @default.
• W2048451330 type Work @default.
• W2048451330 sameAs 2048451330 @default.
• W2048451330 citedByCount "11" @default.
• W2048451330 countsByYear W20484513302015 @default.
• W2048451330 countsByYear W20484513302016 @default.
• W2048451330 countsByYear W20484513302017 @default.
• W2048451330 countsByYear W20484513302018 @default.
• W2048451330 countsByYear W20484513302019 @default.
• W2048451330 countsByYear W20484513302020 @default.
• W2048451330 crossrefType "journal-article" @default.
• W2048451330 hasAuthorship W2048451330A5002974139 @default.
• W2048451330 hasAuthorship W2048451330A5003681868 @default.
• W2048451330 hasAuthorship W2048451330A5006452750 @default.
• W2048451330 hasAuthorship W2048451330A5057117256 @default.
• W2048451330 hasAuthorship W2048451330A5070828891 @default.
• W2048451330 hasAuthorship W2048451330A5078536360 @default.
• W2048451330 hasAuthorship W2048451330A5079244166 @default.
• W2048451330 hasAuthorship W2048451330A5091168983 @default.
• W2048451330 hasBestOaLocation W20484513301 @default.
• W2048451330 hasConcept C104317684 @default.
• W2048451330 hasConcept C119056186 @default.
• W2048451330 hasConcept C121608353 @default.
• W2048451330 hasConcept C126322002 @default.
• W2048451330 hasConcept C134018914 @default.
• W2048451330 hasConcept C150903083 @default.
• W2048451330 hasConcept C190283241 @default.
• W2048451330 hasConcept C207001950 @default.
• W2048451330 hasConcept C2776694085 @default.
• W2048451330 hasConcept C2779761222 @default.
• W2048451330 hasConcept C2781018059 @default.
• W2048451330 hasConcept C2781303535 @default.
• W2048451330 hasConcept C29537977 @default.
• W2048451330 hasConcept C2993294228 @default.
• W2048451330 hasConcept C502942594 @default.
• W2048451330 hasConcept C526584372 @default.
• W2048451330 hasConcept C55493867 @default.
• W2048451330 hasConcept C555283112 @default.
• W2048451330 hasConcept C62112901 @default.
• W2048451330 hasConcept C71924100 @default.
• W2048451330 hasConcept C86803240 @default.
• W2048451330 hasConceptScore W2048451330C104317684 @default.
• W2048451330 hasConceptScore W2048451330C119056186 @default.
• W2048451330 hasConceptScore W2048451330C121608353 @default.
• W2048451330 hasConceptScore W2048451330C126322002 @default.
• W2048451330 hasConceptScore W2048451330C134018914 @default.
• W2048451330 hasConceptScore W2048451330C150903083 @default.
• W2048451330 hasConceptScore W2048451330C190283241 @default.
• W2048451330 hasConceptScore W2048451330C207001950 @default.
• W2048451330 hasConceptScore W2048451330C2776694085 @default.
• W2048451330 hasConceptScore W2048451330C2779761222 @default.
• W2048451330 hasConceptScore W2048451330C2781018059 @default.
• W2048451330 hasConceptScore W2048451330C2781303535 @default.
• W2048451330 hasConceptScore W2048451330C29537977 @default.

• next